Common stock, .001 par value 200,000,000 shares authorized 14,038,902 and 14,007,159 shares issued and 13,918,569 and 13,886,826 outstanding as of july 31, 2026 and april 30, 2026, respectively
14
14
14
14
Treasury stock, at cost
708
708
708
708
Additional paid-in capital
86,080
85,700
85,377
84,985
Accumulated deficit
-81,493
-81,067
-80,400
-80,121
Total stockholders equity attributable to champions oncology, inc
3,893
3,939
4,283
4,170
Non-controlling interest
567
129
95
61
Total stockholders' equity
4,460
4,068
4,378
4,231
Total liabilities and stockholders equity
33,290
26,989
28,447
30,162
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.